P
Ping Chen
Researcher at China Medical University (PRC)
Publications - 5
Citations - 150
Ping Chen is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: microRNA & Cell. The author has an hindex of 5, co-authored 5 publications receiving 120 citations.
Papers
More filters
Journal ArticleDOI
Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis
Xuanzhang Huang,Peng Gao,Jingxu Sun,Yongxi Song,Cheng-che Tsai,Jing Liu,Xiaowan Chen,Ping Chen,Huimian Xu,Zhenning Wang +9 more
TL;DR: NSAIDs and aspirin after but not before diagnosis were associated with improved breast cancer survival, including breast-cancer-specific mortality, all-cause mortality, and relapse/metastasis.
Journal ArticleDOI
Long noncoding RNAs in gastric cancer: functions and clinical applications
TL;DR: The current knowledge of the biological functions and clinical aspects of lncRNAs in GC are reviewed and alterations are linked to the occurrence, progression, and outcome of GC.
Journal ArticleDOI
MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer.
TL;DR: The results of the present study indicate that miR-1258 acts as a tumor suppressor to inhibit invasion and metastasis by targeting HPSE and may serve as a novel biomarker and therapeutic target in the treatment of GC.
Journal ArticleDOI
Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
Xiaowan Chen,Junhua Zhao,Ailin Li,Peng Gao,Jingxu Sun,Yongxi Song,Jingjing Liu,Ping Chen,Zhenning Wang +8 more
TL;DR: It is indicated that aberrant CLDN4 expression plays an important role in the clinicopathological characteristics of GC and is associated with increasing pT category, tumor size, and lymph node metastasis in patients with GC.
Journal Article
Polymorphism in epidermal growth factor is related to clinical outcomes of metastatic colorectal cancer patients treated with cetuximab: a systematic review and meta-analysis.
Xiaoli Lu,Xiaowan Chen,Jingxu Sun,Peng Gao,Yongxi Song,Xuanzhang Huang,Yifan Luo,Ping Chen,Zhenning Wang +8 more
TL;DR: This meta-analysis showed that mCRC patients harboring GG genotype of EGF A61G polymorphism inclined to have a better response rate with cetuximab treatment, and it is proved that EGF polymorphisms may be potential biomarkers for cetUXimab therapeutic strategies.